Source:http://linkedlifedata.com/resource/pubmed/id/16175596
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2005-9-26
|
pubmed:abstractText |
The precise mechanisms responsible for the failure of intrahepatic hepatitis C virus (HCV)-specific CD8+ T cells to control the virus during persistent infection have not been fully defined. We therefore studied the CD8+ T-cell response in 27 HLA-A2-positive patients using four previously well-defined HLA-A2-restricted HCV epitopes. The corresponding HCV sequences were determined in several patients and compared with the intrahepatic HCV-specific CD8+ T-cell response. The results of the study indicate: (1) intrahepatic HCV-specific CD8+ T cells are present in the majority of patients with chronic HCV infection and overlap significantly with the response present in the peripheral blood. (2) A large fraction of intrahepatic HCV-specific CD8+ T cells are impaired in their ability to secrete interferon gamma (IFN-gamma). This dysfunction is specific for HCV-specific CD8+ T cells, since intrahepatic Flu-specific CD8+ T cells readily secrete this cytokine. (3) T-cell selection of epitope variants may have occurred in some patients. However, it is not an inevitable consequence of a functional virus-specific CD8+ T-cell response, since several patients with IFN-gamma-producing CD8+ T-cell responses harbored HCV sequences identical or cross-reactive with the prototype sequence. (4) The failure of intrahepatic virus-specific CD8+ T cells to sufficiently control the virus occurs despite the presence of virus-specific CD4+ T cells at the site of disease. In conclusion, different mechanisms contribute to the failure of intrahepatic CD8+ T cells to eliminate HCV infection, despite their persistence and accumulation in the liver.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0270-9139
|
pubmed:author |
pubmed-author:BlumHubert EHE,
pubmed-author:KerstingNadineN,
pubmed-author:McKinneyDeniseD,
pubmed-author:Neumann-HaefelinChristophC,
pubmed-author:RoggendorfMichaelM,
pubmed-author:SpangenbergHans ChristianHC,
pubmed-author:ThimmeRobertR,
pubmed-author:ViazovSergeiS,
pubmed-author:von WeizsäckerFritzF
|
pubmed:issnType |
Print
|
pubmed:volume |
42
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
828-37
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:16175596-Adult,
pubmed-meshheading:16175596-CD4-Positive T-Lymphocytes,
pubmed-meshheading:16175596-CD8-Positive T-Lymphocytes,
pubmed-meshheading:16175596-Epitopes,
pubmed-meshheading:16175596-Female,
pubmed-meshheading:16175596-Hepacivirus,
pubmed-meshheading:16175596-Hepatitis C, Chronic,
pubmed-meshheading:16175596-Humans,
pubmed-meshheading:16175596-Interferon-gamma,
pubmed-meshheading:16175596-Liver,
pubmed-meshheading:16175596-Male,
pubmed-meshheading:16175596-Middle Aged
|
pubmed:year |
2005
|
pubmed:articleTitle |
Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection.
|
pubmed:affiliation |
Department of Medicine II, University Hospital Freiburg, Freiburg, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|